Opendata, web and dolomites

Rhizomia

A novel cost-efficient bioreactor to accelerate growth of valuable plant roots for nutraceuticals, pharmaceuticals cosmetics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Rhizomia" data sheet

The following table provides information about the project.

Coordinator
BOTALYS 

Organization address
address: QUAI DES USINES 8
city: ATH
postcode: 7800
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website http://www.green2chem.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy)
2. H2020-EU.3.2.1. (Sustainable agriculture and forestry)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-02-01   to  2017-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BOTALYS BE (ATH) coordinator 50˙000.00

Map

 Project objective

From the 391,000 known species, 18,000 have documented medicinal effect and only 150 are industrially cultivated. Their active principles are extracted from wild or cultivated plants, but the production of these compounds is not sufficient to meet the growing market demand. New sustainable production methods include in-vitro cultivation in bioreactors. However, the main limiting factor is the plant biomass growth rate (e.g. state of the art bubble column bioreactors only reach a doubling time of 20-30 days for ginseng roots). Existing bioreactors are therefore unable to produce at an economically viable level sufficient amounts of biomass and active molecules except for rare applications with very high added value (e.g. pharmaceuticals). The project develops a novel bioreactor technology enabling a 2x faster biomass growth and a 2-3x boost in active compound elicitation level. Root bioreactors have been so far designed by pharmaceutical engineers without cost considerations as they target high value application. Our team, coming from a food biotech background, has been able to design low-cost bioreactors compatible with high-volume production where costs can be divided by a factor of 10 to target lower value applications such as nutraceuticals. The project initially focuses on the development of a 30 ton/year pilot plant for ginseng roots, a market of 25,000 ton/year currently dominated by US and Asian producers. In addition, the technology has been validated for 29 other root varieties and has the potential to support in-vitro cultivation of any plant root, covering numerous applications in nutraceuticals, pharmaceuticals, cosmetics, fragrances, pest-control, phyto-protection and food additives, among others.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "RHIZOMIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "RHIZOMIA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.2.4.;H2020-EU.3.2.1.;H2020-EU.2.3.1.;H2020-EU.3.2.2.)

Stoock (2018)

An Innovative Integrated Field Sensor system providing a precise farming tool to reduce productioncosts and water wastage.

Read More  

TEST4ALL (2018)

ANTIBIOTICS CONTROL FOR ALL

Read More  

FucoPol (2017)

An innovative bio-based platform for the cost-competitive production of L-fucose, a building block for Human Milk Oligosaccharides (HMOs).

Read More